Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pathogenic factors, commonly known as virulence factors, are a diverse array of molecules and mechanisms produced by microorganisms such as bacteria, viruses, and fungi to facilitate host infection and disease progression (Casadevall & Pirofski, 2001). These factors allow pathogens to colonize host tissues, evade or suppress the immune system, and obtain essential nutrients (Wu et al., 2008). Representative examples include secreted toxins (e.g., botulinum or Shiga toxins), cell-surface adhesins, and complex protein apparatuses like the Type III secretion system (Galán & Wolf-Watz, 2006). In drug development, targeting these factors is referred to as antivirulence therapy, a strategy aimed at disarming the pathogen rather than killing it, which may minimize the selective pressure for antibiotic resistance (Rasko & Sperandio, 2010). Despite their importance in medicine, the term "Pathogenic factors" is a broad functional category rather than a specific molecular target, and clinical applications require identifying specific proteins or pathways within a single species (NIH, 2023). Drugs such as Bezlotoxumab successfully target specific pathogenic factors, like Clostridioides difficile toxin B, to improve clinical outcomes (Gerding et al., 2018).
Neutralization of secreted toxins, inhibition of adhesion to host cells, or blockade of specialized secretion systems to attenuate pathogen virulence.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogenic factors.